485 related articles for article (PubMed ID: 32570893)
1. Hepatitis B Virus Entry into Cells.
Herrscher C; Roingeard P; Blanchard E
Cells; 2020 Jun; 9(6):. PubMed ID: 32570893
[TBL] [Abstract][Full Text] [Related]
2. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
5. Early events in hepatitis B virus infection: From the cell surface to the nucleus.
Hayes CN; Zhang Y; Makokha GN; Hasan MZ; Omokoko MD; Chayama K
J Gastroenterol Hepatol; 2016 Feb; 31(2):302-9. PubMed ID: 26414381
[TBL] [Abstract][Full Text] [Related]
6. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
7. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
8. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.
Iwamoto M; Saso W; Nishioka K; Ohashi H; Sugiyama R; Ryo A; Ohki M; Yun JH; Park SY; Ohshima T; Suzuki R; Aizaki H; Muramatsu M; Matano T; Iwami S; Sureau C; Wakita T; Watashi K
J Biol Chem; 2020 Jan; 295(3):800-807. PubMed ID: 31836663
[TBL] [Abstract][Full Text] [Related]
9. Innovative HBV Animal Models Based on the Entry Receptor NTCP.
Wettengel JM; Burwitz BJ
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751581
[TBL] [Abstract][Full Text] [Related]
10. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F
Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 inhibits HBV entry through NTCP down regulation.
Bouezzedine F; Fardel O; Gripon P
Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
[TBL] [Abstract][Full Text] [Related]
14. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
15. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP.
Huang H; Huang HC; Chiou WC; Lin LC; Chen JC; Liu HK; Lai YH; Huang C
Antiviral Res; 2021 Nov; 195():105184. PubMed ID: 34627935
[TBL] [Abstract][Full Text] [Related]
16. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.
Lempp FA; Mutz P; Lipps C; Wirth D; Bartenschlager R; Urban S
J Hepatol; 2016 Mar; 64(3):556-64. PubMed ID: 26576481
[TBL] [Abstract][Full Text] [Related]
17. A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses.
de Carvalho Dominguez Souza BF; König A; Rasche A; de Oliveira Carneiro I; Stephan N; Corman VM; Roppert PL; Goldmann N; Kepper R; Müller SF; Völker C; de Souza AJS; Gomes-Gouvêa MS; Moreira-Soto A; Stöcker A; Nassal M; Franke CR; Rebello Pinho JR; Soares MDCP; Geyer J; Lemey P; Drosten C; Netto EM; Glebe D; Drexler JF
J Hepatol; 2018 Jun; 68(6):1114-1122. PubMed ID: 29428874
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
[TBL] [Abstract][Full Text] [Related]
19. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.
Li W; Urban S
J Hepatol; 2016 Apr; 64(1 Suppl):S32-S40. PubMed ID: 27084034
[TBL] [Abstract][Full Text] [Related]
20. NTCP opens the door for hepatitis B virus infection.
Yan H; Liu Y; Sui J; Li W
Antiviral Res; 2015 Sep; 121():24-30. PubMed ID: 26071008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]